| Company name |
|---|
| PharmaDesign, Inc. |
| Head office |
|---|
2-19-8, Hatchobori, Chuo-ku, Tokyo 104-0032 Japan
TEL: +81-3-3523-9630 FAX: +81-3-3523-9631
URL http://www.pharmadesign.co.jp |
| Establishment |
|---|
| January 25, 1999 |
| Chairman of the Board |
|---|
| President and Chief Executive Officer Toshio Furuya, Ph.D. |
| Capital |
|---|
| JPY 447 million |
| Issued Shares |
|---|
| 28,700 |
| Employees |
|---|
| 19 |
| Business |
|---|
Drug discovery research business by integration of bioinformatics and rational drug design.
Contract research business regarding bioinformatics and rational drug design.
Tool product sales business for drug discovery including database, software and focused libraries. |
| History |
|---|
| Jan. 1999 | Established in Tokyo. |
| Mar. 1999 | Commencement of contract research business. |
| Apr. 2001 | Establishment of a laboratory in Yokohama city for drug design. |
| Jul. 2002 | Commencement of sales of Biopendium™ by Inpharmatica Ltd.(a British company). |
| Apr. 2003 | Integration of the head office and the laboratory to a new office in Tokyo. |
| Feb. 2004 | Commencement of sales of PharmaGPEP™, libraries of synthesized peptides. |
| Mar. 2005 | Commencement of sales of Admensa™ by Inpharmatica Ltd.(a British company). |
| Jun. 2005 | Commencement of sales of PharmaGCHEM™, Small-molecule compound libraries focused on GPCRs. |
|
| Board of Directors |
|---|
| President and Chief Executive Officer | Toshio FURUYA | Biography |
| Director | Satoru KANAI | Biography |
| Director | Naoyuki NEMOTO |
| Absentee Director | Teruhisa NOGUCHI | Biography |
| Auditor | Takeshi IMAMURA |
|
